Pathology Deep learning-based assay for programmed death ligand 1 immunohistochemistry scoring in non-small cell lung carcinoma: Does it help pathologists score? April 8, 2024
Immunology | Oncology | Radiology Quantitative Radiological Features and Deep Learning for the Non-Invasive Evaluation of Programmed Death Ligand 1 Expression Levels in Gastric Cancer Patients: A Digital Bopsy Study. November 11, 2022
Oncology | Pathology Artificial intelligence-powered programmed death ligandĀ 1 analyser reduces interobserver variation in tumour proportion score for non-small cell lung cancer with better prediction of immunotherapy response. May 16, 2022